HSF Translational Research Grant Program
HSF Translational Research Grant Program supports early-career faculty pursuing novel hidradenitis suppurativa research to improve patient care and build a foundation for long-term research funding.
Browse similar grants
Funder: Hidradenitis Suppurativa Foundation
Due Dates: December 7, 2026 at midnight (Application deadline)
Funding Amounts: Up to $100,000 in direct costs for one year; up to two awards annually
Summary: Supports novel translational hidradenitis suppurativa research that advances patient care and positions investigators for long-term research funding.
Key Information: Only investigators working in the United States are eligible; the program is intended for early-career faculty.
Description
The Hidradenitis Suppurativa Foundation (HSF) supports novel translational research ideas in hidradenitis suppurativa (HS) that can compete for future long-term funding from the National Institutes of Health or other agencies. The program is intended for early-career faculty and emphasizes rigorous research strategies, innovation, and the potential to improve patient care.
Projects should explore hypotheses grounded in existing knowledge and preliminary studies, using well-reasoned methods and analyses appropriate to their aims. Review considers patient and caregiver input during study conception, design, and completion, alongside diversity in research teams and patient cohorts. Animal research and development of HS animal models may be considered when clearly connected to human translational research.
